- Home
- MTEN vs LSTA Comparison
MTEN vs LSTA Comparison
Compare MTEN & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTEN | LSTA |
|---|---|---|
| Founded | 2015 | 1980 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Misc Health and Biotechnology Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8M | 16.4M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | MTEN | LSTA |
|---|---|---|
| Price | $0.02 | $4.06 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 92.2M | 287.2K |
| Earning Date | 10-01-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $10,735,337.00 | $1,070,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.63 | N/A |
| 52 Week Low | $0.03 | $1.81 |
| 52 Week High | $26.03 | $4.17 |
Technical Indicators
Market Signals| Indicator | MTEN | LSTA |
|---|---|---|
| Relative Strength Index (RSI) | 23.33 | 88.41 |
| Support Level | $0.03 | $2.05 |
| Resistance Level | $0.03 | $4.17 |
| Average True Range (ATR) | 0.21 | 0.15 |
| MACD | -0.00 | 0.21 |
| Stochastic Oscillator | 0.13 | 95.04 |
Price Performance
Historical ComparisonAbout MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.